Delivery Order SPE2DB20D3103-SPE2DB25FQ3B6
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,995.06 by the Defense Logistics Agency on October 27, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of October 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,131.67 on October 24, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by October 27, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken. The delivery order was issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $32,285.78. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and represents performance at the contractor's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging). This firm fixed-price delivery order, valued at $15,328.94, is a non-set-aside award and represents a continuation of the company's significant role in federal medical procurement. The order is expected to be completed by October 22, 2025, with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count supply) with a ceiling value of $15,544.58. The contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a ceiling value of $1,965.60. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3B6Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,029.67. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the Conshohocken, PA location, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.99 million and extending through December 2026. The IDC serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain, demonstrating consistent capability to fulfill federal healthcare requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 9/15/25 |